Clinical Trials Browser

Phase 2 × Carcinoma, Medullary × Temozolomide × Clear all

NCT00869050 2016-07-25

Capecitabine and Temozolomide for Neuroendocrine Cancers

Carcinoid Tumor, Vipoma, Pancreatic Neoplasms, Pheochromocytoma, Somatostatinoma, Zollinger-Ellison Syndrome, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors